These effects, together with a earlier report demonstrating that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like habits in mice,2 assist the idea of focusing on ACKR3 as a unique solution to modulate the opioid procedure, which could open up new therapeutic avenues for opioid-connected Diseases. (2) The health practitioner https://jonathanp257okh6.blog4youth.com/profile